Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Moodys
Dow
Federal Trade Commission
Cerilliant
Chubb
Colorcon
Mallinckrodt

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,588,580

« Back to Dashboard

Summary for Patent: 4,588,580
Title: Transdermal administration of fentanyl and device therefor
Abstract:Transdermal delivery systems for delivery of fentanyl and its analgetically effective derivatives for extended periods of time are disclosed which deliver the base form of the drug at a rate of from 0.5 to 10 .mu.g/cm.sup.2 /hr for a substantial portion of their useful life. The systems can be from 5-100 cm.sup.2 in releasing surface and preferably employ an in-line amine resistant adhesive. Preferred rate controlled systems utilize an aqueous ethanolic gel to minimize drug content.
Inventor(s): Gale; Robert M. (Los Altos, CA), Goetz; Victor (Palo Alto, CA), Lee; Eun S. (Redwood City, CA), Taskovich; Lina T. (Palo Alto, CA), Yum; Su I. (Los Altos, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Application Number:06/633,762
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,588,580
Patent Claim Types:
see list of patent claims
Process; Delivery; Device;

Drugs Protected by US Patent 4,588,580

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 4,588,580

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 4452785 ➤ Try a Free Trial
Australia 565177 ➤ Try a Free Trial
Belgium 902884 ➤ Try a Free Trial
Belgium 905568 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
McKinsey
Johnson and Johnson
Merck
Chinese Patent Office
Moodys
Daiichi Sankyo
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.